309083
Gauging the Public Response to the CVS Caremark Voluntary Ban of Tobacco Products via Twitter
Methods: Crimson Hexagon was used to monitor Twitter conversations using the keywords ‘CVS’ AND ‘tobacco’, ‘cigarette’, OR ‘cigarettes’ from February 5 - 6, 2014. Using the opinion analysis algorithm, conversations collected were categorized to describe the public’s sentiment toward the announcement as well as the main content themes in the conversation.
Results: There were approximately 99,000 related tweets on the day of the announcement, and 25,000 on the following day. Of these, about 36% (N=5,969) more tweets were negative (N=19,035) than were positive (N=13,066). The top Twitter mentions in addition to CVS Caremark were news sources; however, the sources for the top 10 retweeted posts included those such as Marco Rubio and funnyordie and hashtags including #tcot (Top Conservatives on Twitter) and #makesnosense.
Discussion: Twitter data suggest that the public response to CVS Caremark’s announcement to stop selling tobacco products was mixed. While the top Twitter mentions were CVS and news sources, the most popular retweets and hashtags suggest that conservative political and humorous messages were significant themes in the initial public response. Tweet content themes are presented.
Learning Areas:
Public health or related laws, regulations, standards, or guidelinesPublic health or related public policy
Learning Objectives:
Describe the public response to the CVS Caremark announcement ending sales of tobacco products in their stores.
Discuss the dominant popular themes in the Twitter social media activity following the announcement.
Keyword(s): Tobacco Control, Social Media
Qualified on the content I am responsible for because: I have published peer reviewed papers and led studies on tobacco use behaviors, policies, and interventions.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.